The association observed here of reduced SHM and CSR in metastasis-infiltrating B cells compared to B cells infiltrating the primary tumor site in early breast cancer is supported by the reduced expression levels of AICDA, which encodes a key enzyme associated with these processes (Extended Data Fig. 4f). The gene discussed is AICDA; the disease is breast carcinoma.